Tag: Elanco: Page 3

Elanco revenue down 25% on channel inventory reduction

Elanco Animal Health Inc.’s second quarter revenue fell 25%, mostly due to channel inventory reduction and effects from the novel coronavirus (COVID-19) pandemic.

July 30, 2020

Stock Market Indicator And Financial Data View From Led. Double

Elanco under investigation for alleged securities fraud

Elanco Animal Health Inc. is under investigation for securities fraud, and a class action lawsuit has been filed on behalf of investors.

June 11, 2020

fraud-investigation

European Commission OKs Elanco’s acquisition of Bayer unit

The European Commission (EC) has granted approval of Elanco Animal Health Inc.’s pending acquisition of Bayer’s animal health business.

June 9, 2020

Elanco-antibiotics

Elanco 2020 Q1 earnings down 10% due to COVID-19

Find out what actions Elanco took when COVID-19 impacted its commercial distribution partners' liquidity and how it impacted its first quarter earnings.

May 8, 2020

grain-2020-forecast-concept

Elanco donates viral transport media to testing center

Elanco Animal Health is helping in the fight against the novel coronavirus (COVID-19) pandemic by donating a key component for viral testing.

April 15, 2020

Laboratory Tests For Viral Infections. Coronavirus Ncov, Mers-co

ADM, Elanco donate to fight COVID-19 pandemic

Animal health and nutrition companies, including ADM and Elanco Animal Health, have pledged funds to fight the novel coronavirus (COVID-19) pandemic.

March 30, 2020

World Health Coronavirus Outbreak And International Public Infec

Animal Feed Manufacturers

Elanco sells Canada aqua R&D facility to CATC

Elanco Animal Health Inc. has signed an agreement to sell its Victoria, Prince Edward Island, aqua research and development facility to The Center for Aquaculture Technologies Canada (CATC).

December 26, 2019

Page 3 of 3